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Introduction 
Tens of thousands of working-age adults have been dying from 
unexplained end-stage renal disease (ESRD) in Central America and 
South Asia. As the cause of this chronic kidney disease (CKD) remains 
unknown, this condition/these conditions (a unified aetiopathology has 
not been confirmed) have been termed “CKD of Undetermined 
Aetiology” (CKDu). “CKD of Non-Traditional Aetiology”, “Chronic 
Interstitial Nephritis in Agricultural Communities”, “Mesoamerican 
Nephropathy”, “Sri Lankan Agricultural Nephropathy” and “Uddanam 
Nephropathy” are also used but here we use the term CKDu.  
 
The first reports of CKDu, almost 20 years ago, were based on 
observations of an excess of working-age adults from agricultural 
communities in El Salvador and Sri Lanka receiving dialysis, but without 
diagnoses explaining their ESRD[1,2]. Available population-level data now 
support a high prevalence of renal dysfunction in the absence of known 
risk factors in Central America and South Asia[3–5] but the global extent of 
the problem remains unclear (Figure). Lack of access to renal 
replacement therapy (RRT) in many affected areas means death from 
ESRD is common.  
 
Definition 
Although Kidney Disease Improving Global Outcomes criteria can be 
used to identify CKD, defining CKDu is challenging as it rests primarily 
on excluding known causes of disease using clinical and biochemical 
criteria (as imaging and histopathology are often inaccessible)[6]. The use 
of the term CKDu has generally been restricted to individuals with renal 
impairment of unknown cause from agricultural and/or socioeconomically 
deprived populations with a high reported prevalence of CKD (often 
based on a single eGFR measure) in the absence of common 
identifiable aetiologies (e.g. diabetes or glomerulonephritis, as evidenced 
by heavy proteinuria and/or hypertension). It is not typically used to 
describe sporadic cases of ESRD without diagnosis in high-income 
countries. 
 
Even using simple criteria identifying CKDu can be problematic as as 
accessing accurate eGFR testing may be difficult in many low-income 
settings. Furthermore, both the distribution of normal kidney function, 
and the validity of eGFR equations developed elsewhere, are unknown 
in many populations impacted by CKDu.  
 
Clinical features 
CKDu typically presents with asymptomatic renal impairment without 
associated hypertension or heavy proteinuria. Hyperuricaemia is 
prominent in established disease, and “chistata” (dysuria) is described in 
Central America[3]. The histological pattern is similar between regions, 
showing interstitial fibrosis, tubular atrophy and glomerulosclerosis 
without immune-complex or crystal deposition[7]. There is a male 
preponderance. In Central America CKDu often (but not exclusively) 
affects young adult sugarcane workers[3] and loss of eGFR can be 
dramatic[8], whereas in Sri Lanka, the condition occurs more commonly 
in middle-age[4].  
 
Recently, a febrile illness with acute kidney injury (AKI) has been 
reported in populations at risk of CKDu in both Sri Lanka and 
Nicaragua[9]. Biopsies during these episodes demonstrate a non-
granulomatous acute interstitial nephritis (AIN). Although some patients 
with this presentation progress to chronic renal impairment, there is 
currently inadequate evidence that this syndrome is a necessary 
precursor of CKDu.  
 
Aetiology 
Candidate causes of CKDu include metabolic responses to 
heat/dehydration, environmental factors (agrochemicals, metals, 
phyto/mycotoxins), infection and drugs/alcohol but identifying causal 
factors in observational studies has proven challenging. There is 
currently insufficient evidence to support any single cause of disease, 
and an as yet overlooked factor may be responsible. The lead 
hypotheses are discussed below.  
 
Heat/dehydration 
It has been proposed that strenuous manual labour in hot conditions 
without adequate hydration leads to repeated tubular injury and 
subsequent fibrosis. Injury from heat and volume depletion could be 
exacerbated by myoglobin release from muscle and/or urate crystalluria 
and studies have demonstrated a rise in serum creatinine across a 
sugarcane cutting shift[10]. However, whether these changes represent 
creatinine generation or excretion, are transient or sustained, and/or are 
a marker of an underlying lack of reserve in those with pre-existing 
subclinical CKD is unclear. Seasonal drops in eGFR have also been 
proposed to support an occupational cause of disease. However, similar 
annual variation in kidney function is also observed in populations not at 
risk of CKDu. 
 
Agrochemicals 
Poisoning by pesticides (e.g. organophosphates) can lead to AKI raising 
the possibility of an alternative occupational cause of CKDu. Although 
there is evidence from the USA that those working with agrochmicals are 
at increased risk of ESRD, reports from Central America have found 
pesticide applicators do not exhibit excess renal dysfunction[3]. 
 
Metals 
A number of metals have historically been responsible for clusters of 
CKD, but most studies of likely candidates including cadmium, lead, and 
arsenic, conducted in CKDu regions, have not identified higher levels in 
those with renal dysfunction[3,4]. 
 
Infection 
Reports of AIN in the at-risk population raises the possibility of an 
infective aetiology. Studies of leptospira have demonstrated no excess 
seropositivity in those with renal impairment in Central America. 
However, other organisms of known (e.g. hantavirus) or unknown (e.g. 
flaviviruses) nephrotropism are endemic in areas impacted by CKDu.  
 
Management 
Avoidance of nephrotoxic drugs 
Although there is no evidence to support nephrotoxic drugs (non-
steroidal anti-inflammatory drugs, aminoglycosides) as primary causes 
of CKDu, use of these agents is widespread and avoidance should be 
advised in those with established renal dysfunction.   
 
Allopurinol 
Laboratory findings in CKDu have led to the suggestion that urate 
lowering may be useful in ameliorating progressive renal dysfunction. 
There have been no clinical trials, but allopurinol has been used in 
affected regions.  
 
Water, rest, shade 
Labour conditions in areas impacted by CKDu, specifically in Central 
America, are often brutal. Although measures to improve work conditions 
should obviously be supported, there is currently no evidence that such 
interventions prevent CKDu.  
 
RRT 
RRT provision places huge strain on health systems in affected regions. 
Access remains far from universal and, anecdotally, outcomes, 
particularly with peritoneal dialysis in Central America, are poor.  
 
Conclusion 
CKDu leads to premature loss of life at an unprecedented scale in 
agricultural communities in low- and middle-income countries. Such a 
burden of disease is unlikely to have been neglected for so long had it 
been occurring in high-income settings. As the cause remains unclear, 
only methodologically robust studies, conducted in partnership with 
affected communities and local investigators, will provide data on the 
geographical distribution, insights into pathogenesis, and a scientific 





Figure: Countries affected by CKDu. Countries where there is 
population-based evidence of CKDu (red) are in Central America (Pacific 
coastal regions of El Salvador and Nicaragua) and South Asia (north 
central Sri Lanka and northern coastal Andhra Pradesh in southern 
India). There have also been reports of CKDu (gold) in Cameroon, Costa 
Rica, Egypt, Guatemala, Honduras, Mexico, Panama, Saudi Arabia, 
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